Overview
The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event.
The attendees will learn more about the new Australian consensus: treatment goals for moderate to severe psoriasis in the era of targeted therapies and how these groundbreaking “recommendations” have the potential to transform the landscape of psoriasis care. You will learn how advanced targeted therapies fit into the guidelines, providing highly effective and personalised solutions for patients.
At the Brisbane event, A/Prof Peter Foley and A/Prof Erin McMeniman will lead the discussion and present the Australasian Dermatology Registry, particularly exploring the exciting advantages of this new Registry and the opportunities it presents for earning Category 3 CPD.
Don’t miss out on this engaging discussion that promises to unveil the future of psoriasis treatment and professional development. We invite you to be a part of this informative dinner meeting! Limited spots are available!
Agenda
| 6:30pm | Arrival and registration |
| 6:45pm | Advanced Targeted Therapies in the context of new Psoriasis Treatment Goals |
| 7:20pm | Australasian Psoriasis Registry Reimagined |
| 8:30pm | Meeting close |
A/Prof Erin McMeniman
BSc MBBS FRACGP MPH FACD PhD
A/Prof Erin McMeniman practices at Central Brisbane Dermatology and at Princess Alexandra Hospital where she conducts medical dermatology clinics and MDTs in cutaneous lymphoma and hidradenitis suppurativa. Erin completed her PhD in genotypic and phenotypic correlations in patients with multiple primary melanoma. Erin is Chair of the QLD Faculty of Dermatology, she also coordinates the Dermatology teaching program at University of QLD Medical School, is on the Australasian College of Dermatology Academic Research Committee, and Chair of the Aboriginal and Torres Strait Islander Committee.
